top of page
Gloved hands holding petri dish

Antimicrobial Resistance (AMR) Committee

Antimicrobial resistance (AMR) is a growing global health threat, rendering common infections harder to treat and undermining advances in medicine. Driven by factors like overuse of antibiotics and poor infection control, AMR demands urgent action through strengthened stewardship and global cooperation to prevent a post-antibiotic era.

Reports of our past events

The Event Report and Recordings of the Hybrid Event on Bridging Science, Advocacy, and Practice: A Unified Approach to Combating Antimicrobial Resistance

Get The Report

​Upcoming Events

No events at the moment

Insights from Our Blog

Associated Members

Contact Us

Carl Aryan

Partnership & Committees Director

carl.aryan@yahoo.com

Carl is the Partnership & Committees Director at the Infectious Disease Alliance (IDA), where he leads strategic collaboration efforts and oversees the organization’s core thematic committees. His work spans critical areas including antimicrobial resistance (AMR), digital health and technology, and research and clinical trials—with a strong focus on patient relations and community engagement.
With a Medical Doctorate Degree in Dentistry (D.M.D.) and a background in public health research, Carl brings a multidisciplinary approach to advancing IDA’s mission. He is recognized for his contributions to helping patients during the COVID-19 pandemic and now based in Denmark, continues to champion a “One Health” approach to infectious disease challenges.

Carl is the Partnership & Committees Director at the Infectious Disease Alliance (IDA), where he leads strategic collaboration efforts and oversees the organization’s core thematic committees. His work spans critical areas including antimicrobial resistance (AMR), digital health and technology, and research and clinical trials—with a strong focus on patient relations and community engagement. With a Medical Doctorate Degree in Dentistry (D.M.D.) and a background in public health research, Carl brings a multidisciplinary approach to advancing IDA’s mission. He is recognized for his contributions to helping patients during the COVID-19 pandemic and now based in Denmark, continues to champion a “One Health” approach to infectious disease challenges.
bottom of page